Search

everythinglearnresearchcommunity

for

Search:↓

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Eyelashes protect the eyes, but more research is needed to understand how.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

The model and estimator can predict drug exposure in kidney transplant patients well.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

New nanocarriers improve drug delivery for disease treatment.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The document discusses hair and nail conditions, updates on treatments for alopecia, and controversies around finasteride use.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

EZH2 levels decrease as fetuses develop and are higher in adult skin, which may affect skin growth and repair.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

Cedrol may be an effective treatment for colorectal cancer.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Black cumin and its nanoformulations show promise in treating neurodegenerative diseases.